Felix Huth

10PUBLICATIONS

47CO-AUTHORS

Regenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsLiquid biopsiesMetabolic medicine

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jun 27, 2026

PBPK Modeling and Clinical Data Reveal Reduced Impact of CYP3A4 and CYP2C9 Inhibitors on Elimination of Siponimod.

|Mar 28, 2026

Physiologically-Based Pharmacokinetics of Ribociclib Drug-Drug Interactions and Organ Impairment Pharmacokinetics in Early Breast Cancer.

Yan Ji, Felix Huth, Craig Wang

|Mar 20, 2026

Advances in Human Mass Balance Studies: An IQ Consortium Perspective on Current Practices and Emerging Trends.

Jason Boer, Ellen Cannady, Filip Cuyckens

|Mar 18, 2026

Pharmacokinetics of Asciminib 200 mg in the Presence of a Strong CYP3A4 Inducer, Phenytoin, in Healthy Participants.

Matthias Hoch, Amanda J Taylor, Felix Huth

|Dec 17, 2025

Guided Sample Pooling in Human Mass Balance Studies: A Recommended Strategic Decision Framework.

Filip Cuyckens, Wenying Li, Adam M Auclair

|Oct 29, 2024

Clinical Pharmacology of Asciminib: A Review.

Matthias Hoch, Felix Huth, Paul William Manley

Pageof 2

Frequent Collaborators

Cathy Cantalloube

Gregory S Walker

Jason Boer

S Cyrus Khojasteh

Isabel Piel

Matthias Hoch

Ioannis Loisios-Konstantinidis

2 joint publications

Wenying Li

2 joint publications

Filip Cuyckens

1 joint publications

Thomas Faller

Frequent Collaborators

Cathy Cantalloube

Gregory S Walker

Jason Boer

S Cyrus Khojasteh